Breaking News Instant updates and real-time market news.

IRMD

iRadimed

$10.77

-6.24 (-36.68%)

08:01
10/05/16
10/05
08:01
10/05/16
08:01

iRadimed downgraded to Neutral from Buy at Roth Capital

Roth Capital analyst Chris Lewis downgraded iRadimed to Neutral from Buy after the company pre-announced a Q3 miss and reduced its 2016 outlook. While still a believer in iRadimed's technologies and market opportunity over the longer-term, the analyst will look for sales cycle normalization, improving new order activity, margin visibility, and MRI-monitor regulatory progress/commercial launch to gain higher conviction. He also lowered his price target on the shares to $11.50 from $28.

IRMD iRadimed
$10.77

-6.24 (-36.68%)

01/28/16
ROTH
01/28/16
NO CHANGE
ROTH
iRadimed should be bought on weakness, says Roth Capital
Noting that iRadimed's stock has dropped about 25% after it reported higher than expected preliminary Q4 revenue on January 11, Roth Capital thinks that the company's fundamentals remain strong, while its 2016 results will probably exceed its guidance. The firm thinks the sell-off i nthe stock is overdone and it keeps a $30 price target and Buy rating on the shares.
04/04/16
ROTH
04/04/16
NO CHANGE
Target $25
ROTH
Buy
iRadimed price target lowered to $25 from $30 at Roth Capital
Roth Capital analyst Chris Lewis lowered his price target for iRadimed to $25 from $30 to reflect increased regulatory uncertainty. The FDA has denied approval for the company's 510k application for its MRI compatible infusion pump, with iRadimed planning to appeal the decision, the analyst tells investors in a research note. Lewis says the company will continue selling its pump systems domestically while it continues efforts to obtain new FDA clearance. The analyst reiterates a Buy rating on the shares.
06/09/16
ROTH
06/09/16
NO CHANGE
Target $28
ROTH
Buy
Roth Capital sees new regulatory development as positive for iRadimed
Roth Capital analyst Chris Lewis says the FDA has accepted iRadimed 's 510k denial appeal pending certain requests related to software message display changes and will not require additional human factors usability testing. The analyst sees the news as a positive regulatory development for the company and more favorable than his previous expectations. Lewis reiterates a Buy rating on the stock and raised his price target on the shares to $28 from $25 on the improved regulatory outlook.

TODAY'S FREE FLY STORIES

AA

Alcoa

$46.25

-1.25 (-2.63%)

07:41
09/22/17
09/22
07:41
09/22/17
07:41
Downgrade
Alcoa rating change  »

Alcoa downgraded to Hold,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.84

0.17 (0.25%)

07:40
09/22/17
09/22
07:40
09/22/17
07:40
Earnings
CarMax reports Q2 EPS 98c, consensus 95c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

SYK

Stryker

$140.67

-2.04 (-1.43%)

, ZBH

Zimmer Biomet

$113.06

-2.92 (-2.52%)

07:40
09/22/17
09/22
07:40
09/22/17
07:40
Recommendations
Stryker, Zimmer Biomet analyst commentary  »

Growth investors should…

SYK

Stryker

$140.67

-2.04 (-1.43%)

ZBH

Zimmer Biomet

$113.06

-2.92 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SAVE

Spirit Airlines

$34.01

1.31 (4.01%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Conference/Events
Spirit Airlines to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IBM

IBM

$145.26

-0.62 (-0.43%)

, WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Hot Stocks
IBM announces new agreement with Walgreens to deploy IBM retail analytics »

IBM (IBM) announced a new…

IBM

IBM

$145.26

-0.62 (-0.43%)

WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 22

    Oct

  • 25

    Oct

  • 15

    Nov

07:38
09/22/17
09/22
07:38
09/22/17
07:38
Conference/Events
Federal Reserve Bank of Dallas President participates in a conference »

Dallas Federal Reserve…

07:37
09/22/17
09/22
07:37
09/22/17
07:37
Conference/Events
Federal Reserve Bank of Kansas City President to speak at conference »

Kansas City Federal…

MYGN

Myriad Genetics

$33.61

0.1 (0.30%)

07:36
09/22/17
09/22
07:36
09/22/17
07:36
Recommendations
Myriad Genetics analyst commentary  »

Myriad Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$13.41

-0.33 (-2.40%)

, MSFT

Microsoft

$74.21

-0.73 (-0.97%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AMD

AMD

$13.41

-0.33 (-2.40%)

MSFT

Microsoft

$74.21

-0.73 (-0.97%)

INTC

Intel

$37.20

0.13 (0.35%)

ABBV

AbbVie

KMI

Kinder Morgan

$19.32

-0.45 (-2.28%)

GLNG

Golar LNG

$21.34

0.19 (0.90%)

HAS

Hasbro

$94.84

-0.68 (-0.71%)

MIK

Michaels

$21.38

-0.04 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 05

    Oct

  • 22

    Oct

  • 23

    Oct

  • 08

    Nov

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$3.77

0.04 (1.07%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Initiation
Agile Therapeutics initiated  »

Agile Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Dec

SECO

Seeco Holding

07:33
09/22/17
09/22
07:33
09/22/17
07:33
Syndicate
Seeco Holding 8.5M share IPO priced at $13.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

AAXN

Axon

$22.80

-0.11 (-0.48%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Axon receives multiple orders for TASER X26P, TASER X2 smart weapons »

Axon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$35.91

-0.06 (-0.17%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Recommendations
Micron analyst commentary  »

Micron's November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

, MDU

MDU Resources

$26.21

-0.19 (-0.72%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Ferrellgas Partners LP appoints Doran Schwartz as CFO »

Ferrellgas Partners L.P.…

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

MDU

MDU Resources

$26.21

-0.19 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Technical Analysis
Technical View: Finish Line drops after earnings and outlook »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PANW

Palo Alto Networks

$140.06

-1.69 (-1.19%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Conference/Events
Palo Alto Networks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 07

    Dec

  • 11

    Dec

QCOM

Qualcomm

$52.03

0.05 (0.10%)

, NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for shares of NXP Semiconductors »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$52.03

0.05 (0.10%)

NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Sprint, T-Mobile »

Sprint up 2.6% after…

S

Sprint

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

AZN

AstraZeneca

$32.81

-0.12 (-0.36%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Upgrade
AstraZeneca rating change  »

AstraZeneca upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 08

    Nov

SXT

Sensient

$75.90

0.19 (0.25%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Initiation
Sensient initiated  »

Sensient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

, CAR

Avis Budget

$38.08

0.16 (0.42%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

MRVL

Marvell

CAR

Avis Budget

$38.08

0.16 (0.42%)

GIS

General Mills

$51.69

-0.48 (-0.92%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

HOG

Harley-Davidson

$47.96

-0.39 (-0.81%)

JBLU

JetBlue

$18.90

-0.35 (-1.82%)

MXWL

Maxwell

$4.97

-0.155 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 05

    Oct

  • 17

    Oct

  • 08

    Nov

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
T-Mobile, Sprint close to agreeing on deal terms, Reuters reports »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

EADSY

Airbus

$23.07

0.78 (3.50%)

, BA

Boeing

$256.04

0.58 (0.23%)

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
Turkish Airlines mulls Airbus order following Boeing deal, Reuters reports »

Turkish Airlines has…

EADSY

Airbus

$23.07

0.78 (3.50%)

BA

Boeing

$256.04

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.